ANDA 91480, held by Apotex. Famciclovir.
As of Nov 16, 2026, ANDA 91480 (Famciclovir), held by Apotex, was first approved by FDA on Jul 22, 2011, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 22, 2011 | Original application | Approved | None posted |
| Famciclovir125MG · tablet;oral | Famciclovir | Discontinued |
| Famciclovir250MG · tablet;oral | Famciclovir | Discontinued |
| Famciclovir500MG · tablet;oral | Famciclovir | Discontinued |
| Jul 25, 2019 | Supplement 6Labeling · Standard review | Approved | None posted |
| Jul 25, 2019 | Supplement 5Labeling · Standard review | Approved | None posted |
| Mar 4, 2016 | Supplement 2Labeling · Standard review | Approved | None posted |
| Jul 22, 2011 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters